Céline Taveau has over 13 years of market access experience. Céline provides senior leadership for large projects on strategic market access and Health Technology Assessment (HTA)’s for pharmaceutical, vaccine and medical device companies. She has extensive experience with orphan drugs, and oncology indications, immunology, cardiovascular, respiratory and infectiology. Her experience includes market access strategies, systematic literature reviews, value proposition development, French HTA submissions, payer advisory boards and early scientific advice engagements.